TumorGenesis announces license agreement with SyntArray
Precision Therapeutics, formerly Skyline Medical, announced that its wholly owned subsidiary, TumorGenesis, has secured a license agreement with SyntArray LLC. This license agreement will advance the Company’s strategic plan to develop the next generation of patient derived tumor models. March 13, 2018